0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global BioPharma Service Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-37Q12661
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global BioPharma Service Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global BioPharma Service Market Research Report 2025

Code: QYRE-Auto-37Q12661
Report
June 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

BioPharma Service Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

BioPharma Service Market

BioPharma Service Market

The global market for BioPharma Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for BioPharma Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BioPharma Service.
The BioPharma Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global BioPharma Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BioPharma Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of BioPharma Service Market Report

Report Metric Details
Report Name BioPharma Service Market
CAGR 5%
Segment by Type
  • Raw Material
  • In-Process and Product
  • Finished Pharmaceutical
  • Others
Segment by Application
  • Analytical Testing
  • Drug Development Service
  • Drug Packaging and Delivery
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins, Pace Analytical Services, Catalent, Envigo, PPD, Element, ALS, Intertek, SGS, Boston Analytical, EAG, Maxxam, ARL Bio Pharma, West Pharmaceutical, BioScreen, Microbac, RD Laboratories, Analytical Lab Group, Piramal Pharma Solutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of BioPharma Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the BioPharma Service Market report?

Ans: The main players in the BioPharma Service Market are Eurofins, Pace Analytical Services, Catalent, Envigo, PPD, Element, ALS, Intertek, SGS, Boston Analytical, EAG, Maxxam, ARL Bio Pharma, West Pharmaceutical, BioScreen, Microbac, RD Laboratories, Analytical Lab Group, Piramal Pharma Solutions

What are the Application segmentation covered in the BioPharma Service Market report?

Ans: The Applications covered in the BioPharma Service Market report are Analytical Testing, Drug Development Service, Drug Packaging and Delivery, Others

What are the Type segmentation covered in the BioPharma Service Market report?

Ans: The Types covered in the BioPharma Service Market report are Raw Material, In-Process and Product, Finished Pharmaceutical, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global BioPharma Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Raw Material
1.2.3 In-Process and Product
1.2.4 Finished Pharmaceutical
1.2.5 Others
1.3 Market by Application
1.3.1 Global BioPharma Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Analytical Testing
1.3.3 Drug Development Service
1.3.4 Drug Packaging and Delivery
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global BioPharma Service Market Perspective (2020-2031)
2.2 Global BioPharma Service Growth Trends by Region
2.2.1 Global BioPharma Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 BioPharma Service Historic Market Size by Region (2020-2025)
2.2.3 BioPharma Service Forecasted Market Size by Region (2026-2031)
2.3 BioPharma Service Market Dynamics
2.3.1 BioPharma Service Industry Trends
2.3.2 BioPharma Service Market Drivers
2.3.3 BioPharma Service Market Challenges
2.3.4 BioPharma Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top BioPharma Service Players by Revenue
3.1.1 Global Top BioPharma Service Players by Revenue (2020-2025)
3.1.2 Global BioPharma Service Revenue Market Share by Players (2020-2025)
3.2 Global BioPharma Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by BioPharma Service Revenue
3.4 Global BioPharma Service Market Concentration Ratio
3.4.1 Global BioPharma Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by BioPharma Service Revenue in 2024
3.5 Global Key Players of BioPharma Service Head office and Area Served
3.6 Global Key Players of BioPharma Service, Product and Application
3.7 Global Key Players of BioPharma Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 BioPharma Service Breakdown Data by Type
4.1 Global BioPharma Service Historic Market Size by Type (2020-2025)
4.2 Global BioPharma Service Forecasted Market Size by Type (2026-2031)
5 BioPharma Service Breakdown Data by Application
5.1 Global BioPharma Service Historic Market Size by Application (2020-2025)
5.2 Global BioPharma Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America BioPharma Service Market Size (2020-2031)
6.2 North America BioPharma Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America BioPharma Service Market Size by Country (2020-2025)
6.4 North America BioPharma Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe BioPharma Service Market Size (2020-2031)
7.2 Europe BioPharma Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe BioPharma Service Market Size by Country (2020-2025)
7.4 Europe BioPharma Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific BioPharma Service Market Size (2020-2031)
8.2 Asia-Pacific BioPharma Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific BioPharma Service Market Size by Region (2020-2025)
8.4 Asia-Pacific BioPharma Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America BioPharma Service Market Size (2020-2031)
9.2 Latin America BioPharma Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America BioPharma Service Market Size by Country (2020-2025)
9.4 Latin America BioPharma Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa BioPharma Service Market Size (2020-2031)
10.2 Middle East & Africa BioPharma Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa BioPharma Service Market Size by Country (2020-2025)
10.4 Middle East & Africa BioPharma Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins
11.1.1 Eurofins Company Details
11.1.2 Eurofins Business Overview
11.1.3 Eurofins BioPharma Service Introduction
11.1.4 Eurofins Revenue in BioPharma Service Business (2020-2025)
11.1.5 Eurofins Recent Development
11.2 Pace Analytical Services
11.2.1 Pace Analytical Services Company Details
11.2.2 Pace Analytical Services Business Overview
11.2.3 Pace Analytical Services BioPharma Service Introduction
11.2.4 Pace Analytical Services Revenue in BioPharma Service Business (2020-2025)
11.2.5 Pace Analytical Services Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent BioPharma Service Introduction
11.3.4 Catalent Revenue in BioPharma Service Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 Envigo
11.4.1 Envigo Company Details
11.4.2 Envigo Business Overview
11.4.3 Envigo BioPharma Service Introduction
11.4.4 Envigo Revenue in BioPharma Service Business (2020-2025)
11.4.5 Envigo Recent Development
11.5 PPD
11.5.1 PPD Company Details
11.5.2 PPD Business Overview
11.5.3 PPD BioPharma Service Introduction
11.5.4 PPD Revenue in BioPharma Service Business (2020-2025)
11.5.5 PPD Recent Development
11.6 Element
11.6.1 Element Company Details
11.6.2 Element Business Overview
11.6.3 Element BioPharma Service Introduction
11.6.4 Element Revenue in BioPharma Service Business (2020-2025)
11.6.5 Element Recent Development
11.7 ALS
11.7.1 ALS Company Details
11.7.2 ALS Business Overview
11.7.3 ALS BioPharma Service Introduction
11.7.4 ALS Revenue in BioPharma Service Business (2020-2025)
11.7.5 ALS Recent Development
11.8 Intertek
11.8.1 Intertek Company Details
11.8.2 Intertek Business Overview
11.8.3 Intertek BioPharma Service Introduction
11.8.4 Intertek Revenue in BioPharma Service Business (2020-2025)
11.8.5 Intertek Recent Development
11.9 SGS
11.9.1 SGS Company Details
11.9.2 SGS Business Overview
11.9.3 SGS BioPharma Service Introduction
11.9.4 SGS Revenue in BioPharma Service Business (2020-2025)
11.9.5 SGS Recent Development
11.10 Boston Analytical
11.10.1 Boston Analytical Company Details
11.10.2 Boston Analytical Business Overview
11.10.3 Boston Analytical BioPharma Service Introduction
11.10.4 Boston Analytical Revenue in BioPharma Service Business (2020-2025)
11.10.5 Boston Analytical Recent Development
11.11 EAG
11.11.1 EAG Company Details
11.11.2 EAG Business Overview
11.11.3 EAG BioPharma Service Introduction
11.11.4 EAG Revenue in BioPharma Service Business (2020-2025)
11.11.5 EAG Recent Development
11.12 Maxxam
11.12.1 Maxxam Company Details
11.12.2 Maxxam Business Overview
11.12.3 Maxxam BioPharma Service Introduction
11.12.4 Maxxam Revenue in BioPharma Service Business (2020-2025)
11.12.5 Maxxam Recent Development
11.13 ARL Bio Pharma
11.13.1 ARL Bio Pharma Company Details
11.13.2 ARL Bio Pharma Business Overview
11.13.3 ARL Bio Pharma BioPharma Service Introduction
11.13.4 ARL Bio Pharma Revenue in BioPharma Service Business (2020-2025)
11.13.5 ARL Bio Pharma Recent Development
11.14 West Pharmaceutical
11.14.1 West Pharmaceutical Company Details
11.14.2 West Pharmaceutical Business Overview
11.14.3 West Pharmaceutical BioPharma Service Introduction
11.14.4 West Pharmaceutical Revenue in BioPharma Service Business (2020-2025)
11.14.5 West Pharmaceutical Recent Development
11.15 BioScreen
11.15.1 BioScreen Company Details
11.15.2 BioScreen Business Overview
11.15.3 BioScreen BioPharma Service Introduction
11.15.4 BioScreen Revenue in BioPharma Service Business (2020-2025)
11.15.5 BioScreen Recent Development
11.16 Microbac
11.16.1 Microbac Company Details
11.16.2 Microbac Business Overview
11.16.3 Microbac BioPharma Service Introduction
11.16.4 Microbac Revenue in BioPharma Service Business (2020-2025)
11.16.5 Microbac Recent Development
11.17 RD Laboratories
11.17.1 RD Laboratories Company Details
11.17.2 RD Laboratories Business Overview
11.17.3 RD Laboratories BioPharma Service Introduction
11.17.4 RD Laboratories Revenue in BioPharma Service Business (2020-2025)
11.17.5 RD Laboratories Recent Development
11.18 Analytical Lab Group
11.18.1 Analytical Lab Group Company Details
11.18.2 Analytical Lab Group Business Overview
11.18.3 Analytical Lab Group BioPharma Service Introduction
11.18.4 Analytical Lab Group Revenue in BioPharma Service Business (2020-2025)
11.18.5 Analytical Lab Group Recent Development
11.19 Piramal Pharma Solutions
11.19.1 Piramal Pharma Solutions Company Details
11.19.2 Piramal Pharma Solutions Business Overview
11.19.3 Piramal Pharma Solutions BioPharma Service Introduction
11.19.4 Piramal Pharma Solutions Revenue in BioPharma Service Business (2020-2025)
11.19.5 Piramal Pharma Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global BioPharma Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Raw Material
 Table 3. Key Players of In-Process and Product
 Table 4. Key Players of Finished Pharmaceutical
 Table 5. Key Players of Others
 Table 6. Global BioPharma Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global BioPharma Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global BioPharma Service Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global BioPharma Service Market Share by Region (2020-2025)
 Table 10. Global BioPharma Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global BioPharma Service Market Share by Region (2026-2031)
 Table 12. BioPharma Service Market Trends
 Table 13. BioPharma Service Market Drivers
 Table 14. BioPharma Service Market Challenges
 Table 15. BioPharma Service Market Restraints
 Table 16. Global BioPharma Service Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global BioPharma Service Market Share by Players (2020-2025)
 Table 18. Global Top BioPharma Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BioPharma Service as of 2024)
 Table 19. Ranking of Global Top BioPharma Service Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by BioPharma Service Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of BioPharma Service, Headquarters and Area Served
 Table 22. Global Key Players of BioPharma Service, Product and Application
 Table 23. Global Key Players of BioPharma Service, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global BioPharma Service Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global BioPharma Service Revenue Market Share by Type (2020-2025)
 Table 27. Global BioPharma Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global BioPharma Service Revenue Market Share by Type (2026-2031)
 Table 29. Global BioPharma Service Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global BioPharma Service Revenue Market Share by Application (2020-2025)
 Table 31. Global BioPharma Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global BioPharma Service Revenue Market Share by Application (2026-2031)
 Table 33. North America BioPharma Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America BioPharma Service Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America BioPharma Service Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe BioPharma Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe BioPharma Service Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe BioPharma Service Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific BioPharma Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific BioPharma Service Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific BioPharma Service Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America BioPharma Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America BioPharma Service Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America BioPharma Service Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa BioPharma Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa BioPharma Service Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa BioPharma Service Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Eurofins Company Details
 Table 49. Eurofins Business Overview
 Table 50. Eurofins BioPharma Service Product
 Table 51. Eurofins Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 52. Eurofins Recent Development
 Table 53. Pace Analytical Services Company Details
 Table 54. Pace Analytical Services Business Overview
 Table 55. Pace Analytical Services BioPharma Service Product
 Table 56. Pace Analytical Services Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 57. Pace Analytical Services Recent Development
 Table 58. Catalent Company Details
 Table 59. Catalent Business Overview
 Table 60. Catalent BioPharma Service Product
 Table 61. Catalent Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 62. Catalent Recent Development
 Table 63. Envigo Company Details
 Table 64. Envigo Business Overview
 Table 65. Envigo BioPharma Service Product
 Table 66. Envigo Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 67. Envigo Recent Development
 Table 68. PPD Company Details
 Table 69. PPD Business Overview
 Table 70. PPD BioPharma Service Product
 Table 71. PPD Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 72. PPD Recent Development
 Table 73. Element Company Details
 Table 74. Element Business Overview
 Table 75. Element BioPharma Service Product
 Table 76. Element Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 77. Element Recent Development
 Table 78. ALS Company Details
 Table 79. ALS Business Overview
 Table 80. ALS BioPharma Service Product
 Table 81. ALS Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 82. ALS Recent Development
 Table 83. Intertek Company Details
 Table 84. Intertek Business Overview
 Table 85. Intertek BioPharma Service Product
 Table 86. Intertek Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 87. Intertek Recent Development
 Table 88. SGS Company Details
 Table 89. SGS Business Overview
 Table 90. SGS BioPharma Service Product
 Table 91. SGS Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 92. SGS Recent Development
 Table 93. Boston Analytical Company Details
 Table 94. Boston Analytical Business Overview
 Table 95. Boston Analytical BioPharma Service Product
 Table 96. Boston Analytical Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 97. Boston Analytical Recent Development
 Table 98. EAG Company Details
 Table 99. EAG Business Overview
 Table 100. EAG BioPharma Service Product
 Table 101. EAG Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 102. EAG Recent Development
 Table 103. Maxxam Company Details
 Table 104. Maxxam Business Overview
 Table 105. Maxxam BioPharma Service Product
 Table 106. Maxxam Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 107. Maxxam Recent Development
 Table 108. ARL Bio Pharma Company Details
 Table 109. ARL Bio Pharma Business Overview
 Table 110. ARL Bio Pharma BioPharma Service Product
 Table 111. ARL Bio Pharma Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 112. ARL Bio Pharma Recent Development
 Table 113. West Pharmaceutical Company Details
 Table 114. West Pharmaceutical Business Overview
 Table 115. West Pharmaceutical BioPharma Service Product
 Table 116. West Pharmaceutical Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 117. West Pharmaceutical Recent Development
 Table 118. BioScreen Company Details
 Table 119. BioScreen Business Overview
 Table 120. BioScreen BioPharma Service Product
 Table 121. BioScreen Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 122. BioScreen Recent Development
 Table 123. Microbac Company Details
 Table 124. Microbac Business Overview
 Table 125. Microbac BioPharma Service Product
 Table 126. Microbac Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 127. Microbac Recent Development
 Table 128. RD Laboratories Company Details
 Table 129. RD Laboratories Business Overview
 Table 130. RD Laboratories BioPharma Service Product
 Table 131. RD Laboratories Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 132. RD Laboratories Recent Development
 Table 133. Analytical Lab Group Company Details
 Table 134. Analytical Lab Group Business Overview
 Table 135. Analytical Lab Group BioPharma Service Product
 Table 136. Analytical Lab Group Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 137. Analytical Lab Group Recent Development
 Table 138. Piramal Pharma Solutions Company Details
 Table 139. Piramal Pharma Solutions Business Overview
 Table 140. Piramal Pharma Solutions BioPharma Service Product
 Table 141. Piramal Pharma Solutions Revenue in BioPharma Service Business (2020-2025) & (US$ Million)
 Table 142. Piramal Pharma Solutions Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. BioPharma Service Picture
 Figure 2. Global BioPharma Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global BioPharma Service Market Share by Type: 2024 VS 2031
 Figure 4. Raw Material Features
 Figure 5. In-Process and Product Features
 Figure 6. Finished Pharmaceutical Features
 Figure 7. Others Features
 Figure 8. Global BioPharma Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global BioPharma Service Market Share by Application: 2024 VS 2031
 Figure 10. Analytical Testing Case Studies
 Figure 11. Drug Development Service Case Studies
 Figure 12. Drug Packaging and Delivery Case Studies
 Figure 13. Others Case Studies
 Figure 14. BioPharma Service Report Years Considered
 Figure 15. Global BioPharma Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global BioPharma Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global BioPharma Service Market Share by Region: 2024 VS 2031
 Figure 18. Global BioPharma Service Market Share by Players in 2024
 Figure 19. Global Top BioPharma Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BioPharma Service as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by BioPharma Service Revenue in 2024
 Figure 21. North America BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America BioPharma Service Market Share by Country (2020-2031)
 Figure 23. United States BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe BioPharma Service Market Share by Country (2020-2031)
 Figure 27. Germany BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific BioPharma Service Market Share by Region (2020-2031)
 Figure 35. China BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America BioPharma Service Market Share by Country (2020-2031)
 Figure 43. Mexico BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa BioPharma Service Market Share by Country (2020-2031)
 Figure 47. Turkey BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE BioPharma Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Eurofins Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 51. Pace Analytical Services Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 52. Catalent Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 53. Envigo Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 54. PPD Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 55. Element Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 56. ALS Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 57. Intertek Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 58. SGS Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 59. Boston Analytical Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 60. EAG Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 61. Maxxam Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 62. ARL Bio Pharma Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 63. West Pharmaceutical Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 64. BioScreen Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 65. Microbac Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 66. RD Laboratories Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 67. Analytical Lab Group Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 68. Piramal Pharma Solutions Revenue Growth Rate in BioPharma Service Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Metaproteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-5M19888
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-33S19787
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Grade Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6P20101
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Bupivacaine Extended-Release Liposome Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-10L20096
Thu Oct 02 00:00:00 UTC 2025

Add to Cart